Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 9.13
+0.15 (1.67%)
Apr 28, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of 460.41 million as of April 28, 2026. Its market cap has decreased by -13.35% in one year.
Market Cap
460.41M
Enterprise Value
227.73M
Revenue
96.30M
Ranking
n/a
PE Ratio
14.18
Stock Price
9.13
Market Cap Chart
Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 460.41M, an increase of 8,710.49%. That is a compound annual growth rate of 19.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 452.84M | -27.60% |
| Dec 31, 2025 | 625.50M | 3.84% |
| Dec 31, 2024 | 602.36M | -24.90% |
| Dec 29, 2023 | 802.04M | -25.09% |
| Dec 30, 2022 | 1.07B | -20.36% |
| Dec 31, 2021 | 1.34B | 21.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.56B |
| PYC Therapeutics | 1.27B |
| Clarity Pharmaceuticals | 1.16B |
| Opthea | 738.77M |
| Racura Oncology | 517.08M |
| Starpharma Holdings | 303.23M |
| Tetratherix | 240.12M |
| Orthocell | 236.04M |